Oxygenta Pharma

{
  "main_header": {
    "sid": 798135,
    "name": "Oxygenta Pharma",
    "stock_name": "Oxygenta Pharma",
    "full_name": "Oxygenta Pharmaceutical Ltd",
    "name_url": "stocks-analysis/oxygenta-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "50.35",
    "chg": 0.35,
    "chgp": "0.7%",
    "dir": 1,
    "prev_price": "50.00",
    "mcapval": "185.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524636,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE102E01018",
    "curr_date": "Mar 05",
    "curr_time": "",
    "bse_nse_vol": "2.88 k",
    "exc_status": "Active",
    "traded_date": "Mar 05, 2026",
    "traded_date_str": "2026 03 05",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/oxygenta-pharma-798135-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Oxygenta Pharmaceutical Ltd Stock Falls to 52-Week Low of Rs.46",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/oxygenta-pharmaceutical-ltd-stock-falls-to-52-week-low-of-rs46-3869473",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/OxygentaPharmac_priceRelatedfactors_3869473.png",
        "date": "2026-03-04 11:28:43",
        "description": "Oxygenta Pharmaceutical Ltd’s shares declined sharply to a new 52-week low of Rs.46 on 4 March 2026, marking a significant downturn amid a challenging year for the company. This latest low reflects ongoing pressures on the stock, which has underperformed the broader market and its sector over the past twelve months."
      },
      {
        "title": "Oxygenta Pharmaceutical Ltd Stock Falls to 52-Week Low of Rs.46",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/oxygenta-pharmaceutical-ltd-stock-falls-to-52-week-low-of-rs46-3869475",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/OxygentaPharmac_priceRelatedfactors_3869475.png",
        "date": "2026-03-04 11:28:34",
        "description": "Oxygenta Pharmaceutical Ltd’s shares declined sharply to a new 52-week low of Rs.46 today, marking a significant downturn in the stock’s performance amid broader market fluctuations and company-specific concerns."
      },
      {
        "title": "Oxygenta Pharmaceutical Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/oxygenta-pharmaceutical-ltd-is-rated-strong-sell-3862142",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/OxygentaPharmac_mojoScore_3862142.png",
        "date": "2026-02-28 10:10:14",
        "description": "Oxygenta Pharmaceutical Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 01 September 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 February 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Oxygenta Pharmaceutical Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/oxygenta-pharmaceutical-ltd-is-rated-strong-sell-3844240",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/OxygentaPharmac_mojoScore_3844240.png",
        "date": "2026-02-17 10:10:20",
        "description": "Oxygenta Pharmaceutical Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 01 September 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 17 February 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook."
      },
      {
        "title": "Oxygenta Pharmaceutical Ltd Falls to 52-Week Low Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/oxygenta-pharmaceutical-ltd-falls-to-52-week-low-amidst-continued-downtrend-3837757",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/OxygentaPharmac_priceRelatedfactors_3837757.png",
        "date": "2026-02-13 15:10:47",
        "description": "Oxygenta Pharmaceutical Ltd’s shares declined sharply to a new 52-week low of Rs.46.6 today, marking a significant downturn amid broader market weakness and company-specific headwinds. The stock’s performance continues to trail the sector and benchmark indices, reflecting ongoing concerns about its financial health and market positioning."
      },
      {
        "title": "Oxygenta Pharmaceutical Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/oxygenta-pharmaceutical-ltd-is-rated-strong-sell-3824182",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/OxygentaPharmac_mojoScore_3824182.png",
        "date": "2026-02-06 10:10:03",
        "description": "Oxygenta Pharmaceutical Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 01 September 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 06 February 2026, providing investors with the most recent insights into the company’s performance and outlook."
      },
      {
        "title": "Are Oxygenta Pharmaceutical Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-oxygenta-pharmaceutical-ltd-latest-results-good-or-bad-3822934",
        "imagepath": "",
        "date": "2026-02-05 19:29:52",
        "description": "Oxygenta Pharmaceutical Ltd's latest financial results for the quarter ending December 2025 present a complex picture of growth and ongoing operational challenges. The company reported a significant revenue surge of 137.27% quarter-on-quarter, reaching ₹33.93 crores, which reflects a seasonal demand typical in the pharmaceutical sector. However, this top-line growth did not translate into profitability, as the company experienced a net loss of ₹4.84 crores, representing a 23.16% decline year-on-year.\n\nThe operational metrics indicate persistent difficulties. The operating loss widened to ₹4.08 crores, with an operating margin of negative 12.02%. While this margin shows some improvement from the previous quarter, it remains a concern, especially given the negative operating margins reported in the same quarter last year. The company's negative book value of ₹-6.77 per share raises fundamental questions about..."
      },
      {
        "title": "Oxygenta Pharmaceutical Q3 FY26: Losses Deepen Despite Revenue Surge",
        "link": "https://www.marketsmojo.com/news/result-analysis/oxygenta-pharmaceutical-q3-fy26-losses-deepen-despite-revenue-surge-3822462",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/OxygentaPharmac_quaterlyResult_3822462.png",
        "date": "2026-02-05 09:52:51",
        "description": "Oxygenta Pharmaceutical Limited, a micro-cap pharmaceutical company with a market capitalisation of ₹226.00 crores, reported a net loss of ₹4.84 crores for Q3 FY26 (October-December 2025), representing a marginal improvement of 1.83% quarter-on-quarter but a 23.16% deterioration year-on-year. The stock, trading at ₹60.00 as of February 5, 2026, declined 1.70% on the day, reflecting investor concerns about the company's persistent inability to achieve profitability despite robust top-line growth."
      },
      {
        "title": "Why is Oxygenta Pharmaceutical Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-oxygenta-pharmaceutical-ltd-fallingrising-3812242",
        "imagepath": "",
        "date": "2026-01-31 00:53:34",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Context</strong></p>\n<p>Despite opening the day with a gap down of 2%, the stock demonstrated resilience by rallying to an intraday high of ₹64, marking a 6.84% increase from its low point of ₹58.7. This intraday recovery highlights strong buying interest during the session, even as the weighted average price suggests that a larger volume of shares traded closer to the day’s lower price levels. The stock’s ability to rebound from its opening weakness indicates underlying demand that has helped sustain its upward trajectory.</p>\n<p>Oxygenta Pharmaceutical has been on a positive streak, recording gains over the last two consecutive days with an aggregate return of 8.64%. This recent rally is part of a broader trend, as the stock has delivered a remarkable 16.67..."
      }
    ],
    "total": 220,
    "sid": "798135",
    "stock_news_url": "https://www.marketsmojo.com/news/oxygenta-pharmaceutical-798135"
  },
  "announcements": [
    {
      "caption": "Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.",
      "datetime": "20-Feb-2026",
      "details": "Disclosure under Regulation 30 of SEBI (Listing Obligations and Discloure Requirements) Regulations 2015.",
      "source": "BSE"
    },
    {
      "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
      "datetime": "14-Feb-2026",
      "details": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Virupaksha Organics Ltd",
      "source": "BSE"
    },
    {
      "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
      "datetime": "13-Feb-2026",
      "details": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Virupaksha Organics Ltd",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Oxygenta Pharmaceutical Ltd Stock Falls to 52-Week Low of Rs.46

2026-03-04 11:28:43

Oxygenta Pharmaceutical Ltd’s shares declined sharply to a new 52-week low of Rs.46 on 4 March 2026, marking a significant downturn amid a challenging year for the company. This latest low reflects ongoing pressures on the stock, which has underperformed the broader market and its sector over the past twelve months.

Read full news article

Oxygenta Pharmaceutical Ltd Stock Falls to 52-Week Low of Rs.46

2026-03-04 11:28:34

Oxygenta Pharmaceutical Ltd’s shares declined sharply to a new 52-week low of Rs.46 today, marking a significant downturn in the stock’s performance amid broader market fluctuations and company-specific concerns.

Read full news article

Oxygenta Pharmaceutical Ltd is Rated Strong Sell

2026-02-28 10:10:14

Oxygenta Pharmaceutical Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 01 September 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 February 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Oxygenta Pharmaceutical Ltd is Rated Strong Sell

2026-02-17 10:10:20

Oxygenta Pharmaceutical Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 01 September 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 17 February 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.

Read full news article

Oxygenta Pharmaceutical Ltd Falls to 52-Week Low Amidst Continued Downtrend

2026-02-13 15:10:47

Oxygenta Pharmaceutical Ltd’s shares declined sharply to a new 52-week low of Rs.46.6 today, marking a significant downturn amid broader market weakness and company-specific headwinds. The stock’s performance continues to trail the sector and benchmark indices, reflecting ongoing concerns about its financial health and market positioning.

Read full news article

Oxygenta Pharmaceutical Ltd is Rated Strong Sell

2026-02-06 10:10:03

Oxygenta Pharmaceutical Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 01 September 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 06 February 2026, providing investors with the most recent insights into the company’s performance and outlook.

Read full news article

Are Oxygenta Pharmaceutical Ltd latest results good or bad?

2026-02-05 19:29:52

Oxygenta Pharmaceutical Ltd's latest financial results for the quarter ending December 2025 present a complex picture of growth and ongoing operational challenges. The company reported a significant revenue surge of 137.27% quarter-on-quarter, reaching ₹33.93 crores, which reflects a seasonal demand typical in the pharmaceutical sector. However, this top-line growth did not translate into profitability, as the company experienced a net loss of ₹4.84 crores, representing a 23.16% decline year-on-year. The operational metrics indicate persistent difficulties. The operating loss widened to ₹4.08 crores, with an operating margin of negative 12.02%. While this margin shows some improvement from the previous quarter, it remains a concern, especially given the negative operating margins reported in the same quarter last year. The company's negative book value of ₹-6.77 per share raises fundamental questions about...

Read full news article

Oxygenta Pharmaceutical Q3 FY26: Losses Deepen Despite Revenue Surge

2026-02-05 09:52:51

Oxygenta Pharmaceutical Limited, a micro-cap pharmaceutical company with a market capitalisation of ₹226.00 crores, reported a net loss of ₹4.84 crores for Q3 FY26 (October-December 2025), representing a marginal improvement of 1.83% quarter-on-quarter but a 23.16% deterioration year-on-year. The stock, trading at ₹60.00 as of February 5, 2026, declined 1.70% on the day, reflecting investor concerns about the company's persistent inability to achieve profitability despite robust top-line growth.

Read full news article

Why is Oxygenta Pharmaceutical Ltd falling/rising?

2026-01-31 00:53:34

Recent Price Movement and Market Context

Despite opening the day with a gap down of 2%, the stock demonstrated resilience by rallying to an intraday high of ₹64, marking a 6.84% increase from its low point of ₹58.7. This intraday recovery highlights strong buying interest during the session, even as the weighted average price suggests that a larger volume of shares traded closer to the day’s lower price levels. The stock’s ability to rebound from its opening weakness indicates underlying demand that has helped sustain its upward trajectory.

Oxygenta Pharmaceutical has been on a positive streak, recording gains over the last two consecutive days with an aggregate return of 8.64%. This recent rally is part of a broader trend, as the stock has delivered a remarkable 16.67...

Read full news article

View All News